Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

1 Multiple trials, including hundreds of obese/overweight women in the menopausal/postmenopausal age group, reflect weight loss of at least 5% with three months of semaglutide treatment.

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

Potential high value and de-risked development pathway: Existing human safety and tolerability data from ... and semaglutide were equally effective in promoting body weight loss and improving ...

NORTH CAROLINA -- A warning to consumers about fake Ozempic (semaglutide ... Besides the FDA, the FBI also issued this warning about fake compounding weight loss drugs on the market.